U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea flag South Korea · Delayed Price · Currency is KRW
26,850
+900 (3.47%)
At close: Feb 26, 2026

U2Bio Revenue

U2Bio had revenue of 6.87B KRW in the quarter ending September 30, 2025, with 6.81% growth. This brings the company's revenue in the last twelve months to 25.59B, down -2.62% year-over-year. In the year 2024, U2Bio had annual revenue of 25.04B, down -18.68%.

Revenue (ttm)
25.59B
Revenue Growth
-2.62%
P/S Ratio
16.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
427.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202425.04B-5.75B-18.68%
Dec 31, 202330.79B-38.22B-55.38%
Dec 31, 202269.01B58.01B527.29%
Dec 31, 201411.00B1.59B16.90%
Dec 31, 20139.41B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nepes503.41B
Devsisters corporation286.10B
C&C International271.51B
DIT Corp.130.36B
NC Chem119.15B
Humedix110.99B
KOSES Co.,Ltd78.34B
POONGWON PRECISION CO.,Ltd.31.17B
Revenue Rankings